CN Patent

CN105294571B — 一种依鲁替尼中间体及其制备方法和用途

Assigned to Ruibo Suzhou Pharmaceutical Co Ltd · Expires 2019-04-23 · 7y expired

What this patent protects

本发明涉及依鲁替尼技术领域，具体涉及一种依鲁替尼中间体的制备方法及用途，所述中间体具有下列式A结构： 其中虚线表示该位置羰氧之间为双键或为单键；或具有下列式(V)结构：

USPTO Abstract

本发明涉及依鲁替尼技术领域，具体涉及一种依鲁替尼中间体的制备方法及用途，所述中间体具有下列式A结构： 其中虚线表示该位置羰氧之间为双键或为单键；或具有下列式(V)结构：

Drugs covered by this patent

Patent Metadata

Patent number
CN105294571B
Jurisdiction
CN
Classification
—
Expires
2019-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Ruibo Suzhou Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.